Ebers Pharmaceuticals Ltd.
|BSE: 507715||Sector: Health care|
|NSE: N.A.||ISIN Code: INE669D01018|
|BSE 05:30 | 01 Jan||Ebers Pharmaceuticals Ltd|
|NSE 05:30 | 01 Jan||Ebers Pharmaceuticals Ltd|
Ebers Pharmaceuticals Ltd. (EBERSPHARMA) - News Sector
4.52 pm | 16 Jan 2019 | Press Trust of India
These patents are valid through 2036, the company said in a BSE filing
1.24 pm | 16 Jan 2019 | Business Standard
The stock hit a new high of Rs 1,929, outperforming the market by gaining 6 per cent in the past 6 days, as compared to a 1 per cent rise in the S&P B...
6.30 am | 16 Jan 2019 | Business Standard
Globally, the insulin business has come under pressure
2.16 pm | 15 Jan 2019 | Business Standard
The package offers statutory bonus, gratuity and a compensation of 75 days' wages for every completed year of service. An early bird incentive of Rs 7...
3.10 pm | 11 Jan 2019 | Business Standard
The stock rallied 14% to Rs 430, trading at its highest level since November 16, 2018 on the BSE.
10.01 pm | 10 Jan 2019 | Press Trust of India
Ryaltris is indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age
1.18 pm | 10 Jan 2019 | Business Standard
Linde India up 10% to Rs 759, surging 56% since November 7, after the promoter BOC Group has offered to take full ownership of the company and delist ...
10.33 am | 10 Jan 2019 | Business Standard
The stock was up 5 per cent to Rs 207 per share on the BSE, trading at its highest level since January 8, 2008.
4.04 pm | 9 Jan 2019 | Press Trust of India
The drug is manufactured by Novel Laboratories Inc for Baltimore-based Lupin Pharmaceuticals, Inc
10.59 pm | 8 Jan 2019 | Business Standard
Over 1,700 employees were working in these two facilities
2.17 am | 8 Jan 2019 | Business Standard
The Hyderabad-based company is at fifth place in prescription sales, next to Indian counterpart Lupin, in the US
6.42 am | 7 Jan 2019 | Business Standard
Online drug sellers are set to disrupt the brick-and-mortar retailer, provided they are willing and able to meet a difficult, albeit reasonable regime...
8.57 am | 4 Jan 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
11.48 am | 2 Jan 2019 | Business Standard
IOL Chemicals & Pharma rallied 6 per cent to Rs 177 today, surging 122% in the past six months, as compared to a 2.5% rise in the S&P BSE Sensex.
9.02 am | 2 Jan 2019 | Business Standard
Here's a list of top stocks that may remain in focus today -
2.14 pm | 1 Jan 2019 | Press Trust of India
Shilpa Medicare said the US market for Irinotecan HCL is approximately $18 million
9.00 am | 1 Jan 2019 | Business Standard
Here's a look at the top stocks that are likely to remain in focus today -
12.43 am | 1 Jan 2019 | Business Standard
The pharma major acquired a portfolio of central nervous drug system drugs, including NaMuscla, through its acquisition of German drug maker Temmler P...
6.59 pm | 31 Dec 2018 | Press Trust of India
Apte was appointed to the board of IHH Healthcare Berhad in September 2014, Fortis Healthcare said
5.22 pm | 31 Dec 2018 | Business Standard
Nifty outlook and few trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.